Phase 4 N=43 Single-blind Other

Topical Antimicrobial Effectiveness Testing

Antimicrobial Effectiveness

Bottom Line

View on ClinicalTrials.gov: NCT01366417 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Aug 2012

Primary outcome: Primary: Antimicrobial Efficacy — 2.21; 2.25 log 10 colony forming units / cm^2 — p=< 0.05

Study Design & Population

Study type: Interventional
Phase: Phase 4
Interventions: ChloraPrep One-Step (Drug); 70% isopropyl alcohol (Drug)
Age: Adult, Older Adult · 18+ yrs
Sex: All
Sponsor: C. R. Bard
Primary completion: Jun 2011

Outcome Measures

Outcome	Result	p-value
PRIMARY Antimicrobial Efficacy	2.65; 2.60	<0.05 sig
PRIMARY Antimicrobial Efficacy	2.65; 2.60	<0.05 sig

Summary

The primary objective of this study is to measure the antimicrobial effectiveness of ChloraPrep One-Step Frepp Applicator.

Eligibility Criteria

Inclusion Criteria

in good general health
have skin within 6 inches of the test sites that is free of tattoos, dermatoses, abrasions, cuts, lesions or other skin disorders.

Exclusion Criteria

topical or systemic antimicrobial exposure within 14 days prior to the Screen Visit

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01366417). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.